Profile data is unavailable for this security.
About the company
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
- Revenue in CHF (TTM)3.75bn
- Net income in CHF164.92m
- Incorporated2017
- Employees5.91k
- LocationGalenica AGUntermattweg 8BERN 3027SwitzerlandCHE
- Websitehttps://www.galenica.com/
| Holder | Shares | % Held |
|---|---|---|
| UBS Asset Management Switzerland AGas of 31 Dec 2023 | 2.67m | 5.34% |
| Credit Suisse Asset Management (Schweiz) AGas of 31 Dec 2023 | 2.50m | 4.99% |
| Alecta Pension Insurance Mutualas of 31 Dec 2023 | 2.00m | 4.00% |
| The Vanguard Group, Inc.as of 09 May 2024 | 1.83m | 3.67% |
| Z�rcher Kantonalbank (Investment Management)as of 28 Mar 2024 | 1.79m | 3.58% |
| Vontobel Asset Management AGas of 30 Apr 2024 | 1.25m | 2.50% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 1.00m | 2.00% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 849.78k | 1.70% |
| Pictet Asset Management SAas of 31 Jan 2024 | 834.93k | 1.67% |
| BlackRock Fund Advisorsas of 09 May 2024 | 645.26k | 1.29% |
